Azaa Shibl Sayed Mahmoud | South Egypt Cancer Institute

Dr. Azaa Shibl Sayed Mahmoud

Department

Email:

drazzashibl@gmail.com

MIS Email

azzashibl@aun.edu.eg

Mobile

01021880322

Office

Google Scholar

M.D. In Pediatrics (Pediatric Oncology) , South Egypt Cancer Institute Assiut University , 2014

Lecturer South Egypt Cancer Institute, ِِAssiut University , 2015

#	Title	Research Year
1	Pattern and Outcome of Neurological Complications During the Treatment of Pediatric Acute Leukemias in Upper Egypt	2022
2	Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia	2022
3	Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute	2022
4	Assessment of Humoral Immune Recovery in Children with Hematological malignancies after Completion of Chemotherapy	2021
5	First Relapse of Acute Lymphoblastic Leukemia in Children in Upper Egypt: Survival Outcome and Prognostic Factors	2021
6	Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia	2021
7	Pattern of Pediatric Soft Tissue and Bone Sarcomas at South Egypt Cancer Institute, Retrospective Study	2021
8	Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute	2021
9	Prognostic Significance of Absolute Lymphocytic Count Recovery in Pediatric Patients with Acute Lymphoblastic Leukemia at South Egypt Cancer Institute	2019
10	Flowcytometric CD135 Expression and its Impact on Pediatric Acute Lymphoblastic Leukemia at South Egypt Cancer Institute	2018
11	Fms-Like Tyrosine Kinase 3 expression in Childhood Acute lymphoblastic Leukemia at South Egypt Cancer Institute, Assiut University, Egypt	2014